Carmine N. Stengone - CEO and President, Director at Contineum Therapeutics, Inc.

Insider Transactions and Holdings

Entity Type
Individual
Role
CEO and President, Director
Stock Symbol
CTNM on Nasdaq
Industry
Pharmaceutical Preparations
All Insider Reports
All Insider Reports

There are no Buy or Sell transactions made by Carmine N. Stengone since 12/31/2023

Holdings reported by Carmine N. Stengone for Contineum Therapeutics, Inc.

Class Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Class A Common Stock 11.6K $198K $17.05 Apr 4, 2024 Direct
Stock Option (right to buy) 285K May 24, 2024 Direct Class A Common Stock

Transactions reported by Carmine N. Stengone for Contineum Therapeutics, Inc.

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.